Ocean Twist Biotechnology
PrivateLast Round
Series D
Apr 16, 2023
Total Funding Raised
$542.97M
Company Overview
Ocean Twist Biotechnology is a biotechnology company that develops and produces sustainable protein ingredients for aquaculture feed from insects and agricultural by-products.
Sector
Energy & Sustainability
Verticals
Biotechnology, Circular Economy, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ocean Twist Biotechnology Comparables
Compare Ocean Twist Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arbiom | 79% | |
| Volare | 78% | |
| Kidemis AG | 77% |
Ocean Twist Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Apr 16, 2023 | ||||
| Series C Extension | Oct 6, 2020 | ||||
| Series C | Feb 20, 2019 | ||||
| Series B | Dec 14, 2016 | ||||
| Series A | Feb 1, 2014 |
Key People
Founding team and executive leadership
Ocean Twist Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Compagnie du Bois Sauvage | Series C Extension, Series C |
| Demea Sustainable Investment | Series A, Series C, Series B |
| Astanor Ventures | Series C Extension, Series C |
| Agence Nationale de la Recherche | Grant |
| Happiness Capital | Series C Extension, Series C |
| Upfront Ventures | Series C Extension |
| Quadia | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
Monthly visitors increased 82% MoM.
- Oct 9, 2024
Monthly visitors increased 149% MoM.
Ocean Twist Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ocean Twist Biotechnology's valuation, stock price, and market status.
Is Ocean Twist Biotechnology a public or private company?
Ocean Twist Biotechnology is a private company.
What is the current stock price of Ocean Twist Biotechnology?
Ocean Twist Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Ocean Twist Biotechnology worth (valuation)?
Valuation information for Ocean Twist Biotechnology is not publicly available.
Can I buy Ocean Twist Biotechnology stock?
Ocean Twist Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ocean Twist Biotechnology's last funding round?
Ocean Twist Biotechnology's most recent funding round was Series D on April 16, 2023.
Who are the main investors in Ocean Twist Biotechnology?
Key investors in Ocean Twist Biotechnology include Astanor Ventures, Quadia, Future Positive Capital, Bpifrance.
Will Ocean Twist Biotechnology IPO soon?
No public IPO plans have been announced for Ocean Twist Biotechnology.
How can I track Ocean Twist Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ocean Twist Biotechnology's secondary market activity and sign up for updates.